L293-2539 Screening compound: 2-[5-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonamido]-N-(4-fluoro-2-methylphenyl)propanamide

L293-2539 Screening compound: 2-[5-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonamido]-N-(4-fluoro-2-methylphenyl)propanamide
L293-2539 Screening compound: 2-[5-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonamido]-N-(4-fluoro-2-methylphenyl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L293-2539
2-[5-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonamido]-N-(4-fluoro-2-methylphenyl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L293-2539

Molecular Formula

C22H23FN4O4S (C22 H23 FN4 O4 S)

Compound Name

2-[5-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonamido]-N-(4-fluoro-2-methylphenyl)propanamide

IUPAC name

2-[5-(5-cyclopropyl-124-oxadiazol-3-yl)-2-methylbenzenesulfonamido]-N-(4-fluoro-2-methylphenyl)propanamide

SMILES

CC(C(Nc(cc1)c(C)cc1F)=O)NS(c1c(C)ccc(-c2noc(C3CC3)n2)c1)(=O)=O

InChI

InChI=1S/C22H23FN4O4S/c1-12-4-5-16(20-25-22(31-26-20)15-6-7-15)11-19(12)32(29,30)27-14(3)21(28)24-18-9-8-17(23)10-13(18)2/h4-5,8-11,14-15,27H,6-7H2,1-3H3,(H,24,28)/t14-/m0/s1

InChI Key

VLIFNORDHRTALU-AWEZNQCLSA-N

MDL Number (MFCD)

MFCD27241649

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

458.51

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.672

Distribution Coefficient, logD

4.670

Water Solubility, LogSw

-4.37

Polar Surface Area

95.967

Acid Dissociation Constant (pKa)

9.73

Base Dissociation Constant (pKb)

-1.18

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

31.80

L293-2539 in Drug Discovery

Included in Screening Libraries

Nucleic Acid Ligands (8311 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Others
Mechanism of action:
  • Epigenetic
  • Epigenetic

References: we are preparing a list of scientific research reports with L293-2539 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L293-2539?
Check Price and Availability of L293-2539, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L293-2539 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L293-2539
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L293-2539
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L293-2539 available by request